Skip to main content
SpringerLink
Log in

Mutation analysis of CBL-C and SPRED3 on 19q in human glioblastoma

  • Letter to the Editors
  • Published:
Neurogenetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hartmann C, Johnk L, Kitange G, Wu Y, Ashworth LK, Jenkins RB, Louis DN (2002) Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19. Cancer Res 62:4100–4108

    CAS  PubMed  Google Scholar 

  2. Dikic I, Giordano S (2003) Negative receptor signalling. Curr Opin Cell Biol 15:128–135

    Article  CAS  PubMed  Google Scholar 

  3. Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, Penninger J, Lipkowitz S (1999) cbl-3: a new mammalian cbl family protein. Oncogene 18:3365–3375

    Article  CAS  PubMed  Google Scholar 

  4. Kato R, Nonami A, Taketomi T, Wakioka T, Kuroiwa A, Matsuda Y, Yoshimura A (2003) Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation. Biochem Biophys Res Commun 302:767–772

    Article  CAS  PubMed  Google Scholar 

  5. Thien CB, Walker F, Langdon WY (2001) RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Mol Cell 7:355–365

    CAS  PubMed  Google Scholar 

  6. Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K, Tsuneoka M, Komiya S, Baron R, Yoshimura A (2001) Spred is a Sprouty-related suppressor of Ras signalling. Nature 412:647–651

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Neuro-Oncology Laboratory and Molecular Pathology Unit, Department of Pathology, Cancer Center and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA

    Masahiro Mizoguchi, Catherine L. Nutt & David N. Louis

  2. Molecular Pathology Unit, 149–7151, Massachusetts General Hospital—East, 149 Thirteenth Street, Charlestown, MA 02129, USA

    David N. Louis

Authors
  1. Masahiro Mizoguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catherine L. Nutt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David N. Louis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David N. Louis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mizoguchi, M., Nutt, C.L. & Louis, D.N. Mutation analysis of CBL-C and SPRED3 on 19q in human glioblastoma. Neurogenetics 5, 81–82 (2004). https://doi.org/10.1007/s10048-003-0164-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10048-003-0164-x

Keywords

Search

Navigation